Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: A cross-sectional study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Flensner, Gullvi ^a,b   Landtblom, Anne Marie ^a   Söderhamn, Olle ^b,c   Ek, Anna Christina ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY WEST   (Sweden)

^c UNIVERSITY OF AGDER   (Norway)

Author keywords

Cognition; Education; Emotional distress; Heat sensitivity; Regression analysis

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SOCIOECONOMICS; WORK CAPACITY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; WORK CAPACITY EVALUATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874940265     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-224     Document Type: Article

References (54)

1. Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: a case-control study. Hamilton WT, Hall GH, Round AP, Brit J Gen Pract 2001 51 553 558 (Pubitemid 32640420)
2. An epidemiological approach to study fatigue in the working population: the Maastricht cohort study. Kant IJ, Bültmann U, Schröer K, Beurskens A, van Amelsvoort L, Swaen G, Occup Env Med 2003 60 Suppl I 32 i39
3. Fatigue in relation to perceived health: people with MS compared to people in the general population. Flensner G, Ek A-C, Landtblom A-M, Söderhamn O, Scand J Caring Sci 2008 22 3 391 400 10.1111/j.1471-6712.2007. 00542.x 18840223
4. Prevalence and correlates of fatigue among persons with HIV infection. Sullivan PS, Dworkin MS, and the Adult and Adolescent Spectrum of HIV Disease Investigators, J Pain Symptom Manage 2003 25 329 333 10.1016/S0885-3924(02) 00676-0 12691684 (Pubitemid 36411788)
5. Fatigue. Piper BF, Pathophysiological phenomena in nursing. Human responses to illness Philadelphia: Saunders, Carrieri-Kohlman V, Lindsey A, West C, Third 2003 Chapter 11
6. Lived experience of MS-related fatigue-a phenomenological interview study. Flensner G, Ek A-C, Söderhamn O, Int J Nurs Stud 2003 40 707 717 10.1016/S0020-7489(03)00010-5 12965162 (Pubitemid 37083502)
7. Fatigue in the general population: a translation and psychometric properties of the Norwegian version of the fatigue severity scale. Lerdal A, Wahl AK, Rustøen T, Hanestad BR, Moum T, Scand J Publ Health 2004 32 1 8 10.1080/14034940410024194
8. Symptomatic fatigue in multiple sclerosis. Freal J, Kraft G, Coryell J, Arch Phys Med Rehabil 1984 65 135 138 6703889 (Pubitemid 14197598)
9. Fatigue in multiple sclerosis. Krupp LB, Christodoulou C, Curr Neurol Neurosci 2001 I 294 298
10. Getting the work done: a qualitative study of individuals with multiple sclerosis. Yorkston KM, Johnson K, Klasner ER, Amtmann D, Kuehn CM, Dudgeon B, Disabil Rehabil 2003 25 369 379 10.1080/0963828031000090506 12745946 (Pubitemid 36626491)
11. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Amato MP, Ponziani G, Rossi F, Leidi CL, Stefaile C, Rossi L, J Neurol Sci 2006 243 39 45 10.1016/j.jns.2005.11.025 16434057
12. The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis. Ghaem H, Borhani Haghighi A, Ann Indian Acad Neurol 2008 11 4 236 241 10.4103/0972-2327.44559 19893680
13. The natural history of MS. Vukusic S, Confavreux C, Handbook of multiple sclerosis New York: Marcel Dekker Inc, Cook SD, Third 2001 433 447
14. Mortality statistics for multiple sclerosis and amytrophic lateral sclerosis in Sweden. Boström I, Riise T, Landtblom AM, Neuroepidemiology 2012 38 4 245 249 10.1159/000338031 22678224
15. European Multiple Sclerosis Platform (EMSP), A code of good practice on the rights and quality of life of people affected by multiple sclerosis 2008 http://www.emsp.org/attachments/article/134/1code08.pdf
16. High nationwide prevalence of multiple sclerosis in Sweden. Ahlgren C, Odén A, Lycke J, Mult Scler 2011 17 8 901 908 10.1177/1352458511403794 21459810
17. High prevalence of multiple sclerosis in the Swedish county of värmland. Boström I, Callander M, Kurtzke JF, Landtblom AM, Mult Scler 2009 15 1253 1262 10.1177/1352458509345909 19805442
18. Sex ratio of multiple sclerosis in the national Swedish MS register (SMSreg). Boström I, Stawiarz L, Landtblom AM, Mult Scler 2013 19 1 46 52 10.1177/1352458512446169 22711712
19. Health problems and health-related quality of life in people with multiple sclerosis. Forbes A, While A, Mathes L, Griffiths P, Clin Rehabil 2006 20 67 78 10.1191/0269215506cr880oa 16502752 (Pubitemid 43246334)
20. Longitudinal correlates of fatigue in multiple sclerosis. Patrick E, Christodoulou C, Krupp LB, on behalf of the New York State MS Consortium, Mult Scler 2009 15 258 261 19181775
21. Fatigue and declines in cognitive functioning in multiple sclerosis. Krupp L, Elkins L, Neurology 2000 55 7 934 939 11061247
22. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Rao SM, Leo GJ, Bernardin L, Unverzagt F, Neurology 1991 41 685 691 10.1212/WNL.41.5.685 2027484
23. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F, Neurology 1991 41 692 696 10.1212/WNL.41.5.692 1823781
24. Cognitive functioning in children and adolescents with multiple sclerosis. MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB, Neurology 2005 64 1422 1425 10.1212/01.WNL.0000158474.24191.BC 15851734 (Pubitemid 40570512)
25. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis. Christodoulou C, Melville P, Scherl WF, Morgan T, MacAllister W, Canfora DM, Berry SA, Krupp LB, JINS 2005 11 614 619 16212689 (Pubitemid 41478995)
26. How long can you keep working with benign multiple sclerosis? Glad SB, Nyland H, Aarseth JH, Riise T, Myhr KM, J Neurol Neurosurg Psychiatry 2011 82 1 78 82 10.1136/jnnp.2010.210732 20802029
27. Fatigue in multiple sclerosis is related to disability, depression and quality of life. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignan H, J Neurol Sc 2006 243 1-2 39 45
28. Effects of temperature in multiple sclerosis: a review of the literature. Syndulko K, Jafari M, Woldanski A, Baumhefner RW, Tourtellotte WW, J Neurol Rehabil 1996 10 23 34 (Pubitemid 126054084)
29. The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis. Flensner G, Lindencrona C, J Adv Nurs 2002 37 541 550 10.1046/j.1365-2648.2002.02129.x 11879418
30. A prospective study of fatigue in multiple sclerosis. Lerdal A, Celius EG, Krupp L, Dahl AA, Eur J Neurol 2007 14 1338 1343 10.1111/j.1468-1331.2007. 01974.x 17903208 (Pubitemid 350135298)
31. Sensitivity to heat in MS patients: a factor strongly influencing symptomology-an exploratory survey. Flensner G, Ek A-C, Söderhamn O, Landtblom AM, BMC Neurol 2011 11 27 10.1186/1471-2377-11-27 21352533
32. MS and heat-the smoke and the fire. Meier DS, Christodoulou C, Neurology 2012 78 938 939 10.1212/WNL.0b013e31824de2ac 22402854
33. Warmer outdoor temperature is associated with worse cognitive status in multiple sclerosis. Leavitt VM, Sumowski JF, Chiaravalloti N, DeLuca J, Neurology 2012 78 964 968 10.1212/WNL.0b013e31824d5834 22402861
34. Costs and quality of life of multiple sclerosis in Sweden. Berg J, Lindgren P, Fredrikson S, Kobelt G, Eur J Health Econ 2006 7 Suppl 2 75 S 85
35. Social consequences of multiple sclerosis 1): early pension and temporary unemployment-a historical prospective cohort study. Pfleger CC, Flachs EM, Koch-Henriksen N, Mult Scler 2010 16 1 121 126 10.1177/1352458509352196 20007430
36. Sick leave and professional assistance for multiple sclerosis individuals in Västerbotten County, northern Sweden. Sundström P, Nyström L, Svenningsson A, Forsgren L, Mult Scler 2003 9 5 515 520 10.1191/ 1352458503ms955oa 14582779 (Pubitemid 37287733)
37. Effect of treatment with Natalizumab on ability to work in people with MS-Productivity gain based on a direct measurement of working capacity before and after 1 year of treatment. Olofsson S, Wickström A, Häger Glenngård A, Persson U, Svenningsson A, Bio Drugs 2011 25 5 299 306
38. Early immunotherapy in MS reduces the risk of later disability. Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Andersen O, Lakartidningen 2007 104 22 1684 1688 17601317
39. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neilley LK, Goodin DS, Goodkin DE, Hauser SL, Neurol 1996 46 552 553 10.1212/WNL.46.2.552
40. Multiple sclerosis associated fatigue during natalizumab treatment. Putzki N, Yaldizli O, Tettenborn B, Diener HC, J Neurol Sc 2009 285 109 113 10.1016/j.jns.2009.06.004
41. The Swedish MS registry points out an important clinical problem: physical and psychological fatigue is a main symptom in multiple sclerosis. Landtblom AM, Flensner G, Callander M, Stawiarz L, Lakartidningen 2004 101 44 3456 3457 15560662 (Pubitemid 39486155)
42. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Kurtzke J, Neurol 1983 33 1444 1452 10.1212/WNL.33.11.1444 (Pubitemid 14237132)
43. The MOS 36-item short form healthy survey (SF-36). I. Conceptual framework and item selection. Ware JE, Sherbourne CD, Med Care 1992 30 6 473 483 10.1097/00005650-199206000-00002 1593914
44. The Swedish SF-36 health survey-1. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Sullivan M, Karlsson J, Ware J Jr, Soc Sci Med 1995 41 1349 1358 10.1016/0277-9536(95)00125-Q 8560302
45. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. Sullivan M, Karlsson J, J Clin Epidemiol 1998 51 1105 1113 10.1016/S0895-4356(98)00102-4 9817128 (Pubitemid 28527166)
46. Performance of the Swedish SF- 36 2.0. Taft C, Karlsson J, Sullivan M, Qual Life Res 2004 13 251 256 15058805
47. Fatigue in multiple sclerosis. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC, Arch Neurol 1988 45 435 437 10.1001/archneur.1988.00520280085020 3355400 (Pubitemid 18098285)
48. The Swedish occupational fatigue inventory in people with multiple sclerosis. Johansson S, Ytterberg C, Back B, Widén Holmquist L, von Koch L, J Rehab Med 2008 40 737 743
49. Coefficient alpha and the internal structure of tests. Cronbach LJ, Psychometrika 1951 16 297 334 10.1007/BF02310555
50. A survey of multiple sclerosis. Part I: perceived cognitive problems and compensatory strategy used. Sullivan JIL, Edgeley K, Dehoux E, Can J Rehabil 1990 4 99 105
51. Streiner DL, Norman GR, Health measurement scales Oxford: Oxford University Press Fourth A practical guide to their development and use. 2008
52. The hospital anxiety and depression scale. Zigmond AS, Snaith RP, Acta Psychiat Scand 1983 67 6 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820 (Pubitemid 13098606)
53. WMA, World Medical Association, Declaration of Helsinki: ethical principles for medical research involving human subjects Seoul, Korea: 59th WMA General Assembly 2008
54. Self-rated health and employment status in patients with multiple sclerosis. Krokavcova M, Naqyova I, Van Dijk JP, Rosenberger J, Gavelova M, Middel B, Szilasiova J, Gdovinova Z, Groothoff JW, Disabil Rehabil 2010 32 21 1742 1748 10.3109/09638281003734334 20350069